Vanguard Global Advisers »

Tarsus Pharmaceuticals shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Tarsus Pharmaceuticals (TARS) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Tarsus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Tarsus Pharmaceuticals held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tarsus Pharmaceuticals by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.2M 16k 70.15

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Tarsus Pharmaceuticals

Deep Track Capital
BlackRock
Rtw Investments
Paradigm Biocapital Advisors
Vanguard Group
Henderson Group
Morgan Stanley
Vanguard Capital Management
Jennison Associates
Assenagon Asset Management
Bank of America Corporation
Tang Capital Management
Driehaus Capital Management
Geode Capital Management
State Street Corporation

View all funds holding Tarsus Pharmaceuticals